A Comparison Between Orthodontic and Non-orthodontic Patients on Oral Indexes and Salivary pH and Quality

April 15, 2025 updated by: Andrea Scribante, University of Pavia

A Comparison Between Orthodontic and Non-orthodontic Patients on Oral Indexes and Salivary pH and Quality: Cross-sectional Study

This study aims to assess the caries susceptibility in pediatric patients aged 6-14 years old using Saliva-Check Buffer salivary tests. A total of 40 patients will be enrolled, divided into two groups:

  1. Group A (Pre-Orthodontic Treatment): this group will include pediatric patients who have completed dental treatments (mechanical debridement, fillings, extractions) and have not yet started orthodontic treatment.
  2. Group B (Orthodontic Treatment): this group will consist of pediatric patients who have been undergoing orthodontic treatment for at least 6 months.

Study Overview

Status

Not yet recruiting

Detailed Description

This study aims to assess the caries susceptibility in pediatric patients aged 6-14 years old using Saliva-Check Buffer salivary tests. A total of 40 patients will be enrolled, divided into two groups:

  1. Group A (Pre-Orthodontic Treatment): this group will include pediatric patients who have completed dental treatments (mechanical debridement, fillings, extractions) and have not yet started orthodontic treatment.
  2. Group B (Orthodontic Treatment): this group will consist of pediatric patients who have been undergoing orthodontic treatment for at least 6 months.

Ethical Considerations: the study will be conducted in accordance with the Declaration of Helsinki and the norms of the Good Clinical Practice.

Patient Enrollment: patients meeting the inclusion criteria will be identified from the dental clinic's patient records. Parents or legal guardians will be approached to obtain informed consent for participation in the study.

Baseline Assessment: baseline dental examinations will be conducted to assess the dental health status of each patient, recording the following indexes: DMFT (Decayed, Missing, Filled Teeth), DMFS, PCR. Then, saliva collection and testing will be performed with Saliva-Check Buffer.

Data Analysis: data will be statistically analysed. Normality test will be performed, and a parametric or non-parametric test will be performed to compare the two groups for all the variables tested. Significance threshold will be predefined for p<0.05.

Study Type

Observational

Enrollment (Estimated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Lombardy
      • Pavia, Lombardy, Italy, 27100
        • Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Patients recruited from the Unit of Orthodontics and Pediatric Dentistry, Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy

Description

Inclusion Criteria:

  • Patients about to begin orthodontic treatment or already undergoing orthodontic therapy
  • Willingness to undergo Saliva-Check Buffer salivary tests.
  • Parental or legal guardian consent for participation in the study.

Exclusion Criteria:

  • Patients with systemic medical conditions that may affect the results of salivary tests.
  • Patients unwilling or unable to cooperate for saliva sample collection required for the tests.
  • Patients who have taken antibiotics or other medications that could influence saliva composition in the weeks prior to testing.
  • Patients with oral anomalies that may interfere with data collection or affect test results.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pre-Orthodontic group
Patients from this group are candidate to orthodontic treatment
Saliva-Check buffer test will be used to perform evaluations on saliva pH, quantity and quality
Orthodontic group
Patients from this group are undergoing an orthodontic treatment
Saliva-Check buffer test will be used to perform evaluations on saliva pH, quantity and quality

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
DMFT (Decayed, Missing, Filled Teeth)
Time Frame: Baseline
Sum of decayed, missing due to caries, and filled teeth.
Baseline
DMFS (Decayed, Missing, Filled Surfaces)
Time Frame: Baseline
Sum of decayed, missing due to caries, and filled tooth surfaces.
Baseline
PCR (Plaque Control Record)
Time Frame: Baseline
Number of surfaces with plaque / Total number of surfaces examined) x 100 using disclosing Tri Plaque ID gel.
Baseline
Saliva Check Buffer test
Time Frame: Baseline
Complete assessment of saliva quality, quantity and pH
Baseline
Frankl Behavioral Scale
Time Frame: Baseline

Classification of patients based on cooperation during treatment, using a scale from 1 to 4:

  • 1: Definitely positive Good rapport with the dentist, interested in the dental procedures, laughing and enjoying the situation.
  • 2: Positive Acceptance of treatment; at times cautious, willingness to comply with the dentist, at times with reservation but patient follows the dentist's directions cooperatively.
  • 3: Negative Reluctant to accept treatment; uncooperative, some evidence of negative attitude but not pronounced, i.e. /sullen, withdrawn.
  • 4: Definitely negative Refusal of treatment, crying forcefully, fearful or any other overt evidence of extreme negativism.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrea Scribante, DDS, PhD, University of Pavia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 15, 2025

Primary Completion (Estimated)

May 30, 2025

Study Completion (Estimated)

June 4, 2025

Study Registration Dates

First Submitted

April 3, 2025

First Submitted That Met QC Criteria

April 3, 2025

First Posted (Actual)

April 11, 2025

Study Record Updates

Last Update Posted (Actual)

April 18, 2025

Last Update Submitted That Met QC Criteria

April 15, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2025-SALIVARYPH

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data will be available upon motivated request to the Principal Investigator

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Plaque

Clinical Trials on Saliva-Check Buffer test and periodontal charting

3
Subscribe